Akebia Therapeutics (AKBA) Preferred Dividend Payments (2013 - 2014)
Akebia Therapeutics (AKBA) posted quarterly Preferred Dividend Payments of -$1000.0 for Q3 2014, down 100.04% year-over-year from $2.7 million in Q3 2013, and down 200.0% quarter-over-quarter from $1000.0 in Q2 2014.
Akebia Therapeutics (AKBA) Preferred Dividend Payments (2013 - 2014) Analysis & Trends
Akebia Therapeutics (AKBA) has reported Preferred Dividend Payments for 2 consecutive years, with -$1000.0 the latest figure, recorded in Q3 2014.
- In Q3 2014, Preferred Dividend Payments fell 100.04% year-over-year to -$1000.0; the TTM figure through Dec 2014 stood at $86.9 million (up 55.5% YoY), while the FY2014 annual figure was $86.9 million, up 55.49% from the prior year.
- Preferred Dividend Payments slipped to -$1000.0 in Q3 2014 per AKBA's latest filing, from $1000.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $86.9 million in Q1 2014 and bottomed at -$1000.0 in Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Akebia Therapeutics | 247.60 Mn | 92.06 Mn | 38.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | -1,000.00 |
| Jun 30, 2014 | 1,000.00 |
| Mar 31, 2014 | 86.90 Mn |
| Dec 31, 2013 | 3.02 Mn |
| Sep 30, 2013 | 2.75 Mn |
| Jun 30, 2013 | 49.27 Mn |
| Mar 31, 2013 | 848,125.00 |